Top Markets
Coin of the day
Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX
Clasificación en acciones #210
Boston Scientific Corporation develops, manufactures, and markets medical... Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Precio por acción
$62.83
Capitalización bursátil
$93.23B
Cambio (1 día)
-9.17%
Cambio (1 año)
-31.36%
País
US
Comercio Boston Scientific Corporation (BSX)

Categoría

EPS de Boston Scientific Corporation (BSX)
EPS a fecha de December 2025 TTM: $1.96
Según los últimos informes financieros y el precio de las acciones de Boston Scientific Corporation, el EPS actual de la empresa (TTM) es $1.96. Al final del año 2024, la empresa tenía un EPS de $1.26 un aumento con respecto a al EPS de 2023, que fue de $1.08.
Historial de EPS de Boston Scientific Corporation desde 2000 hasta 2026
EPS al final de cada año
Año EPS Cambiar
2026 (TTM) $1.96 0.00%
2025 $1.96 55.56%
2024 $1.26 16.61%
2023 $1.08 140.75%
2022 $0.45 -35.19%
2021 $0.69 -952.83%
2020 $-0.08 -102.40%
2019 $3.38 179.14%
2018 $1.21 1,412.50%
2017 $0.08 -69.23%
2016 $0.26 -244.44%
2015 $-0.18 100.00%
2014 $-0.09 0.00%
2013 $-0.09 -96.89%
2012 $-2.89 -1,096.55%
2011 $0.29 -141.43%
2010 $-0.70 2.94%
2009 $-0.68 -50.00%
2008 $-1.36 312.12%
2007 $-0.33 -88.26%
2006 $-2.81 -469.74%
2005 $0.76 -40.16%
2004 $1.27 122.81%
2003 $0.57 23.91%
2002 $0.46 -807.69%
2001 $-0.07 -114.13%
2000 $0.46 0.00%
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
$3.74 90.82%
US
$8.49 333.16%
US
$3.59 83.16%
IE
$3.59 83.16%
IE
$1.10 -43.73%
DE